HEUKING advises INMED shareholders on sale to LOGEX group

A Hamburg-based HEUKING team, led by Partner Christoph Prochnau, LL.B., legally advised the shareholders of INMED (Angewandte Informatik für medizinisches Controlling INMED GmbH) on the sale of the company to LOGEX Healthcare Analytics AG.

Founded in 2000 with operations in Lucerne and Hamburg, INMED has become a leading provider of solutions for strategic hospital management and control. Focused on analyzing and simplifying complex data within healthcare, INMED has developed a suite of tools that support medical controlling, market analysis, strategic planning, and comprehensive management reporting, all through its innovative SMARTlize! platform. Serving over 300 healthcare institutions across the German-speaking region in Europe, INMED collaborates with key industry organizations, including the Swiss National Association for Quality Development in Hospitals and Clinics (ANQ), and has played a significant role in advancing quality management standards in healthcare.

LOGEX is a European leader in healthcare data analytics, transforming complex data into actionable insights that empower healthcare decision-makers to balance affordability, access, and quality of care effectively. Headquartered in Amsterdam and supported by an international team of over 400 experts, LOGEX serves more than 1,300 healthcare providers across Europe. Through data-driven decision-making, LOGEX helps providers improve patient outcomes, making high-quality care more accessible and affordable.

Counsel to INMED
HEUKING:
Christoph Prochnau, LL.B. (Lead, Corporate/M&A),
Dr. Henrik Lay (Tax),
Dr. Volker Voth (Employment),
Caroline Frohnwieser,
Katharina Waszczynski,
Larissa Krebs (all Corporate/M&A), all Hamburg